RXRX reports Wednesday, Feb 24, 2027, after the close. After the last 4 reports the stock moved −3.9%, −4.2%, +1.8%, +6.8% the next day.
RXRX is expected to report on Wednesday, Feb 24, 2027, after the close (US Eastern time).
| Report | EPS est. | EPS | Next day | Week |
|---|---|---|---|---|
| Nov 2, 2026 | -0.23 | -0.22 | −3.9% | −0.7% |
| Aug 5, 2026 | -0.23 | -0.25 | −4.2% | +1.2% |
| May 6, 2026 | -0.26 | -0.22 | +1.8% | −6.5% |
| Feb 25, 2026 | -0.32 | -0.21 | +6.8% | +0.3% |
| Nov 5, 2025 | -0.38 | -0.36 | −0.8% | −5.8% |
| Aug 5, 2025 | -0.35 | -0.41 | −4.7% | −8.8% |
| May 5, 2025 | -0.52 | -0.50 | −16.6% | −24.0% |
| Feb 28, 2025 | -0.42 | -0.53 | −2.1% | −18.6% |
Average move the next trading day over the last 8 reports: ±5.1% (2 of 8 up).
RXRX is in a downtrend, momentum soft. $2.5 is the level overhead; $2 the first support below.
RXRX at $2.45. Nearest resistance $2.50 (+2.0%). Nearest support $2.00 (−18.4%).
RXRX chart, levels and analysis · Latest analysis: Recursion Pharmaceuticals (RXRX) stock analysis, November 20, 2026: bearish outlook with high conviction · Earnings this week
RXRX is expected to report on Wednesday, Feb 24, 2027, after the close.
RXRX reports after the close, US Eastern time.
After its report on Nov 2, 2026, RXRX moved −3.9% the next trading day.
Over the last 8 reports, RXRX moved 5.1% on average the next trading day, up 2 times out of 8.
Updated Nov 3, 2026 · Methodology · Research & education, not advice. Dates from company calendars via Yahoo Finance; moves from daily closes.
MarketCrew provides AI-generated market analysis and tools for informational and educational purposes only. Nothing here is investment advice or a recommendation to buy or sell any security, and it is not tailored to your circumstances. MarketCrew is not a registered investment adviser or broker-dealer. Markets involve risk, including the possible loss of principal — do your own research. © MarketCrew.